XML 28 R15.htm IDEA: XBRL DOCUMENT v3.25.0.1
Earnings Per Share
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share

4. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings (loss) per share for the years ended December 31, 2024, 2023 and 2022 (in thousands, except per share amounts):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Acadia Healthcare
    Company, Inc.

 

$

255,612

 

 

$

(21,667

)

 

$

273,139

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding for basic
   earnings per share

 

 

91,621

 

 

 

90,949

 

 

 

89,680

 

Effects of dilutive instruments

 

 

438

 

 

 

—

 

 

 

1,875

 

Shares used in computing diluted earnings per
   common share

 

 

92,059

 

 

 

90,949

 

 

 

91,555

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share attributable to Acadia
   Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

Basic

 

$

2.79

 

 

$

(0.24

)

 

$

3.05

 

Diluted

 

$

2.78

 

 

$

(0.24

)

 

$

2.98

 

Approximately 0.7 million, 0.3 million and 0.1 million shares of common stock issuable upon exercise of outstanding stock options were excluded from the calculation of diluted earnings per share for the years ended December 31, 2024, 2023 and 2022, respectively, because their effect would have been anti-dilutive. For the year ended December 31, 2023, approximately 0.9 million outstanding shares of restricted stock and shares of common stock issuable upon exercise of outstanding stock option awards have been excluded in the calculation of weighted-average shares outstanding-diluted. These shares are excluded from the calculation of diluted earnings per share in the consolidated statement of operations because the net loss for December 31, 2023 causes such securities to be anti-dilutive.